MOFFETT FIELD, CA--(Marketwire - February 08, 2011) - Singularity University (SU) -- the academic institution with the goal of preparing the next generation of leaders to utilize exponential technologies in addressing humanity's grand challenges -- today announced a new industry specific program: "FutureMed2011.com" focused on exploring the impact of rapidly developing technologies on the cutting edge and future of health and biomedicine.
Medicine is poised to evolve dramatically through exponential technologies which range from those which enable ever more powerful imaging, smaller and more capable implantable devices, minimally invasive robotic mediated surgery, brain computer interfaces, to personalized and targeted gene and cancer based therapies.
"Few fields have more potential than the healthcare and biomedicine arena to be so positively changed through exponential technologies," said Peter Diamandis MD, co-founder and Chairman of Singularity University and also founder of the X-prize. "I'm extremely excited for SU to offer the FutureMed executive program to forward thinking physicians and biomedical innovators. This will go beyond the lecture and workshop models of typical medical conferences or business programs and will create a real-world community for sharing medical ideas, knowledge and information."
Singularity University offers highly interactive, four- to seven-day Exponential Technologies Executive Programs for executives, investors, and entrepreneurs. The faculty includes some of the world’s most distinguished leaders in their respective fields. These programs focus on preparing executives for the disruptive business opportunities and challenges resulting from exponential technologies.
The FutureMed executive program is designed uniquely for physicians (CME credit will be offered), medical executives, investors and entrepreneurs who are interested in understanding the powerful forces being unleashed into the medical field by areas such as genomics, the digitization of health data, robotics, artificial intelligence, nanomaterials, stem cell technology, systems medicine, bioinformatics, and synthetic biology.
FutureMed will inform and prepare physicians and senior healthcare executives to understand and recognize the opportunities and disruptive influences of exponentially growing technologies within medicine and healthcare. It will enable them to understand how many rapidly developing and converging fields are affecting the cutting edge, and the future of clinical practice and biomedical industry. The program brings together leading thinkers and practitioners who will discuss and in many cases demonstrate what is in the lab and transitioning to the bedside today and where technology will likely enter the wellness and clinical arena in the next two to 10 years, and beyond. Breakthrough developments ranging from 3D printing to organ regeneration, from point-of-care lab-on-a-chip diagnostics to large-scale bioinformatics; from synthetic biology to new genomic therapies -- all of these topics and more are discussed in the context of the current transition from paper charts to the digitization of biomedical information, electronic health records and distributed healthcare and the evolution of technology to integrate medical practice.
Through a series of faculty speakers, panels, hands on experiences, site visits and in-depth workshops, and late night discussions, participants will complete this intensive 5-day program with new relationships, insights into unmet needs, trends, business concepts, and collaborations that will transform the world of healthcare, from wellness, prevention, diagnosis and therapy. Core tracks will explore the exponential trends in: Information & Data Driven Healthcare, Personalized Medicine, Regenerative Medicine, NeuroMedicine, and Med/Biotech and Entrepreneurship. FutureMed will also examine the policy and ethical implications associated with these trends.
"The acceleration of science and technology within biomedicine makes it more important than ever for clinicians, researchers, policy-makers, and business leaders to understand and approach the potential opportunities and risks of new technologies in a thoughtful and nuanced way," said Neil Jacobstein, President of Singularity University.
FutureMed faculty include Daniel Kraft, MD a Stanford & Harvard trained hematologist/oncologist and stem cell researcher, and Chair for the Medicine track at Singularity University, Catherine Mohr MD, Director of Medical Research at Intuitive Surgical, Thomas Goetz, Executive Editor of WIRED. Roni Zeiger MD, Chief Health Strategist at Google, Dean Ornish MD, Founder of the Preventative Medicine Institute, Christopher DeCharms PhD, neuroscientist and founder of Omneuron Inc, Michael Gillam MD, Director of the Microsoft Medical Media Lab, David Ewing Duncan Director of the Center of Life Science Policy at UC Berkeley and author of the 'Experimental Man', Andrew Kogelnick MD PhD, Founder of The Open Medicine Institute, Christopher Longhurst MD, Chief Medical Information Officer for Stanford's Lucille Packard Children's Hospital, Jordan Shlain MD, founder of Current Health, Dan Riskin MD, Stanford University Surgery & Biodesign Program, Allan May, CEO of Life Sciences Angels, Raymond McCauley PhD of Illumina & Co-founder of Genomera, Michael West PhD, Founder of Geron and CEO of BioTime Pharmaceuticals. Additional Singularity University faculty across multiple disciplines will also be participating.
FutureMed will be held at the NASA Ames Research Park in the heart of Silicon Valley on May 10-15th. Tuition includes meals, site visits and lodging for participants on the NASA Research Park campus. For more information and to register see http://FutureMed2011.com
ABOUT SINGULARITY UNIVERSITY
Singularity University (SU) is an interdisciplinary university whose mission is to assemble, educate and inspire a cadre of leaders who strive to understand and facilitate the development of exponentially advancing technologies in order to address humanity's grand challenges. With the support of a broad range of leaders in academia, business, and government, SU hopes to stimulate groundbreaking, disruptive thinking, and solutions aimed at solving some of the planet's most pressing challenges. SU is based at the NASA Ames Research Park in Silicon Valley. Corporate partners include Google, Autodesk, The Kauffman Foundation for Entrepreneurship, and ePlanet Ventures, Nokia, and others. For more information, visit www.singularityu.org, follow SU on www.twitter.com/singularityu and at www.facebook.com/singularityu.
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati:
